These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2237137)

  • 1. Measles in Israel, the West Bank, and Gaza: continuing incidence and the case for a new eradication strategy.
    Tulchinsky TH; Abed Y; Ginsberg G; Shaheen S; Friedman JB; Schoenbaum ML; Slater PE
    Rev Infect Dis; 1990; 12(5):951-8. PubMed ID: 2237137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles: summary of worldwide impact.
    Assaad F
    Rev Infect Dis; 1983; 5(3):452-9. PubMed ID: 6878998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costs and benefits of a second measles inoculation of children in Israel, the West Bank, and Gaza.
    Ginsberg GM; Tulchinsky TH
    J Epidemiol Community Health; 1990 Dec; 44(4):274-80. PubMed ID: 2126028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles during the Gulf War: a public health threat in Israel, the West Bank, and Gaza.
    Tulchinsky TH; Belmaker I; Raabi S; Acker C; Arbeli Y; Lobel R; Abed Y; Toubassi N; Goldberg E; Slater PE
    Public Health Rev; 1992-1993; 20(3-4):285-96. PubMed ID: 1343365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles control in developing and developed countries: the case for a two-dose policy.
    Tulchinsky TH; Ginsberg GM; Abed Y; Angeles MT; Akukwe C; Bonn J
    Bull World Health Organ; 1993; 71(1):93-103. PubMed ID: 8440043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of measles in Israel: short- and long-term intervention strategies.
    Tulchinsky TH
    Isr J Med Sci; 1991 Jan; 27(1):22-9. PubMed ID: 1995496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles in Mexico.
    Fernandez de Castro J
    Rev Infect Dis; 1983; 5(3):422-6. PubMed ID: 6878993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measles epidemic in Romania, 1996-1998: assessment of vaccine effectiveness by case-control and cohort studies.
    Hennessey KA; Ion-Nedelcu N; Craciun MD; Toma F; Wattigney W; Strebel PM
    Am J Epidemiol; 1999 Dec; 150(11):1250-7. PubMed ID: 10588086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measles containment in Israel.
    Slater PE
    Isr J Med Sci; 1991 Jan; 27(1):19-21. PubMed ID: 1995495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulse mass measles vaccination across age cohorts.
    Agur Z; Cojocaru L; Mazor G; Anderson RM; Danon YL
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11698-702. PubMed ID: 8265611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 1991 measles epidemic in Israel.
    Slater PE; Roitman M; Costin C
    Public Health Rev; 1992-1993; 20(1-2):41-51. PubMed ID: 1305976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of herd immunity in control of measles.
    Black FL
    Yale J Biol Med; 1982; 55(3-4):351-60. PubMed ID: 7180027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Child mortality following standard, medium or high titre measles immunization in West Africa.
    Knudsen KM; Aaby P; Whittle H; Rowe M; Samb B; Simondon F; Sterne J; Fine P
    Int J Epidemiol; 1996 Jun; 25(3):665-73. PubMed ID: 8671571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The resurgence of measles in the United States, 1989-1990.
    Atkinson WL; Orenstein WA; Krugman S
    Annu Rev Med; 1992; 43():451-63. PubMed ID: 1580601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles antibody prevalence after mass immunization campaign in Niterói, state of Rio de Janeiro, Brazil.
    Oliveira SA; Siqueira MM; Mann GF; Costa AJ; Almeida MT; Stavola MS; Tomasini H; Nascimento JP
    Rev Inst Med Trop Sao Paulo; 1996; 38(5):355-8. PubMed ID: 9293077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decay of maternally derived measles antibody in a highly vaccinated population in southern Israel.
    Dagan R; Slater PE; Duvdevani P; Golubev N; Mendelson E
    Pediatr Infect Dis J; 1995 Nov; 14(11):965-9. PubMed ID: 8584363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of measles in Israel: implications of a long-term partial immunization program.
    Swartz TA
    Public Health Rep; 1984; 99(3):272-7. PubMed ID: 6429725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan.
    Chiu HH; Lee CY; Chih TW; Lee PI; Chang LY; Lin YJ; Hsu CM; Huang LM
    J Med Virol; 1997 Jan; 51(1):32-5. PubMed ID: 8986946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of AIK-C measles vaccine in infants at 6 months with Schwarz vaccine at 9 months: a randomized controlled trial in Ghana.
    Nkrumah FK; Osei-Kwasi M; Dunyo SK; Koram KA; Afari EA
    Bull World Health Organ; 1998; 76(4):353-9. PubMed ID: 9803586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Status of measles in The Gambia, 1981.
    Williams PJ; Hull HF
    Rev Infect Dis; 1983; 5(3):391-4. PubMed ID: 6878988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.